Earlier, in 2024, NATCO had invested US$8 million in eGenesis through NATCO Pharma (Canada) Inc. Upon completion of the ...

Zydus informed that the USFDA conducted cGMP inspection for the company’s manufacturing plant at SEZ II, Ahmedabad. The ...

Novotech is set to acquire Adelaide-based Agilex Biolabs from a wholly owned subsidiary of Australian healthcare company ...

Lupin Limited has secured tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application ...

Sun Pharmaceutical Industries Limited has entered into an exclusive licensing pact with US-based LIB Therapeutics Inc. The ...

Amneal said the product will launch immediately, adding another complex injectable to its growing Affordable Medicines ...

MSD, which operates as Merck & Co., Inc in the US and Canada markets, recently inaugurated the Tech Centre's expanded ...

The National Institute for Health and Care Research (NIHR) has launched a new £45 million funding drive aimed at tackling ...

The filing marks a major regulatory step for Gossamer as it seeks to bring seralutinib to patients with pulmonary arterial ...

Hikal Limited shareholders have approved the appointment of Sameer Hiremath as Chairman & Managing Director for a five-year ...

Astellas Pharma has dosed the first patient in a Phase 3 trial testing its investigational cancer drug setidegrasib in ...

Morepen Laboratories Limited has achieved a key milestone by filing its first Abbreviated New Drug Application (ANDA) with ...